TherapeuticsMD, Inc.
TXMD
$1.17
-$0.03-2.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.66% | 78.78% | -104.85% | -114.24% | -104.71% |
| Total Depreciation and Amortization | -13.50% | 16.08% | -5.30% | -19.31% | -38.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -76.10% | 103.57% | 98.85% | 102.47% | 101.46% |
| Change in Net Operating Assets | 123.90% | 109.52% | 93.28% | -355.43% | -20.80% |
| Cash from Operations | 109.41% | 101.52% | 94.95% | 92.68% | -93.54% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 74.09% | -44.67% | 27.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -583.33% | -578.53% |
| Cash from Financing | -- | -- | 101.81% | 100.83% | 100.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.90% | 101.63% | 81.82% | 32.42% | 1.72% |